BamSEC and AlphaSense Join Forces
Learn More

GT Biopharma Inc. – Indentures

NASDAQ: GTBP    
Share price (10/1/26): $6.20    
Market cap (10/1/26): $11.2 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 15 pages Common Stock Vesting Warrants GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.7
from 10-Q 13 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.49
from S-1 13 pages Form of Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.6
from 10-Q 16 pages Pre-Funded Warrant to Purchase Shares of Common Stock GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Vesting Warrants GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.10
from S-3 18 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 18 pages Series B Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 19 pages Series a Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.37
from S-1/A 17 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.36
from S-1/A 18 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.35
from S-1/A 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 10-K 5 pages Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc
12/34/56